Schütte, H <br/><br/>
The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs.  [electronic resource] 

 -  American journal of physiology. Lung cellular and molecular physiology  Sep 2000 
 - L496-502 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1040-0605 
<br/><br/><label>Standard No.: </label>10.1152/ajplung.2000.279.3.L496  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Blood Pressure--drug effects<br/>Capillary Permeability--drug effects<br/>Compliance<br/>Cyclic GMP--metabolism<br/>Female<br/>In Vitro Techniques<br/>Ischemia--metabolism<br/>Male<br/>Nitric Oxide--physiology<br/>Organ Size--drug effects<br/>Phosphodiesterase Inhibitors--pharmacology<br/>Pulmonary Artery--physiopathology<br/>Pulmonary Circulation--drug effects<br/>Purinones--pharmacology<br/>Rabbits<br/>Reperfusion Injury--metabolism